TD Cowen assumed coverage on shares of Anteris Technologies Global (NASDAQ:AVR – Free Report) in a research report released on Tuesday, Marketbeat reports. The brokerage issued a buy rating and a $15.00 price target on the stock.
Several other analysts have also recently commented on the stock. Cantor Fitzgerald initiated coverage on shares of Anteris Technologies Global in a research note on Tuesday. They issued an “overweight” rating and a $9.00 target price for the company. Barclays initiated coverage on shares of Anteris Technologies Global in a research report on Tuesday. They issued an “overweight” rating and a $22.00 price objective for the company.
Get Our Latest Analysis on Anteris Technologies Global
Anteris Technologies Global Trading Up 2.5 %
Anteris Technologies Global Company Profile
Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.
See Also
- Five stocks we like better than Anteris Technologies Global
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Disney: Forging a 3-Headed Sports Streaming Giant With Fubo Deal
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- How Buffett’s Best and Worst Stock Bets Have Fared 5 Years Later
- How to Invest in the Best Canadian Stocks
- Bill Ackman’s Bold Case for Fannie Mae and Freddie Mac
Receive News & Ratings for Anteris Technologies Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anteris Technologies Global and related companies with MarketBeat.com's FREE daily email newsletter.
